Sign up for the premium plan and unlock all options
After purchasing the premium plan, you will unlock all information about drug prices and their availability.
Search
Listing 36921 - 36940 out of 558245 entries
| Country | ATC | Drug name | Drug form, strength, package | Price level | Price in € | Price in local currency | Therapeutic areas | Manufacturer / Importer |
|---|---|---|---|---|---|---|---|---|
| Australia | (L01EA02) dasatinib (adm: O) | Sprycel 70 mg tablet, 60 | Tablet 70 mg, 60 pcs | Wholesale price without vat |
$0-0 |
$0-0 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma;Leukemia, Myelogenous, Chronic, BCR-ABL Positive | Bristol-MyersSquibbAustraliaPtyLtd |
| Australia | (L01EA02) dasatinib (adm: O) | Sprycel 70 mg tablet, 60 | Tablet 70 mg, 60 pcs | Retail price without vat |
$0-0 |
$0-0 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma;Leukemia, Myelogenous, Chronic, BCR-ABL Positive | Bristol-MyersSquibbAustraliaPtyLtd |
| Australia | (L01EA02) dasatinib (adm: O) | Sprycel 70 mg tablet, 60 | Tablet 70 mg, 60 pcs | Wholesale price without vat |
$0-0 |
$0-0 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma;Leukemia, Myelogenous, Chronic, BCR-ABL Positive | Bristol-MyersSquibbAustraliaPtyLtd |
| Australia | (L01EA02) dasatinib (adm: O) | Sprycel 70 mg tablet, 60 | Tablet 70 mg, 60 pcs | Retail price without vat |
$0-0 |
$0-0 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma;Leukemia, Myelogenous, Chronic, BCR-ABL Positive | Bristol-MyersSquibbAustraliaPtyLtd |
| Australia | (L01EA02) dasatinib (adm: O) | Sprycel 70 mg tablet, 60 | Tablet 70 mg, 60 pcs | Wholesale price without vat |
$0-0 |
$0-0 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma;Leukemia, Myelogenous, Chronic, BCR-ABL Positive | Bristol-MyersSquibbAustraliaPtyLtd |
| Australia | (L01EA02) dasatinib (adm: O) | Sprycel 70 mg tablet, 60 | Tablet 70 mg, 60 pcs | Retail price without vat |
$0-0 |
$0-0 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma;Leukemia, Myelogenous, Chronic, BCR-ABL Positive | Bristol-MyersSquibbAustraliaPtyLtd |
| Australia | (L01EA02) dasatinib (adm: O) | Sprycel 70 mg tablet, 60 | Tablet 70 mg, 60 pcs | Wholesale price without vat |
$0-0 |
$0-0 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma;Leukemia, Myelogenous, Chronic, BCR-ABL Positive | Bristol-MyersSquibbAustraliaPtyLtd |
| Australia | (L01EA02) dasatinib (adm: O) | Sprycel 70 mg tablet, 60 | Tablet 70 mg, 60 pcs | Retail price without vat |
$0-0 |
$0-0 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma;Leukemia, Myelogenous, Chronic, BCR-ABL Positive | Bristol-MyersSquibbAustraliaPtyLtd |
| Australia | (L01EA02) dasatinib (adm: O) | Sprycel 70 mg tablet, 60 | Tablet 70 mg, 60 pcs | Wholesale price without vat |
$0-0 |
$0-0 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma;Leukemia, Myelogenous, Chronic, BCR-ABL Positive | Bristol-MyersSquibbAustraliaPtyLtd |
| Australia | (L01EA02) dasatinib (adm: O) | Sprycel 70 mg tablet, 60 | Tablet 70 mg, 60 pcs | Retail price without vat |
$0-0 |
$0-0 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma;Leukemia, Myelogenous, Chronic, BCR-ABL Positive | Bristol-MyersSquibbAustraliaPtyLtd |
| Australia | (L01EA02) dasatinib (adm: O) | Sprycel 70 mg tablet, 60 | Tablet 70 mg, 60 pcs | Wholesale price without vat |
$0-0 |
$0-0 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma;Leukemia, Myelogenous, Chronic, BCR-ABL Positive | Bristol-MyersSquibbAustraliaPtyLtd |
| Australia | (L01EA03) nilotinib (adm: O) | Tasigna 150 mg capsule, 120 | Capsule 150 mg (as hydrochloride monohydrate), 120 pcs | Retail price without vat |
$0-0 |
$0-0 |
Leukemia, Myelogenous, Chronic, BCR-ABL Positive | NovartisPharmaceuticalsAustraliaPtyLimited |
| Australia | (L01EA03) nilotinib (adm: O) | Tasigna 150 mg capsule, 120 | Capsule 150 mg (as hydrochloride monohydrate), 120 pcs | Retail price without vat |
$0-0 |
$0-0 |
Leukemia, Myelogenous, Chronic, BCR-ABL Positive | NovartisPharmaceuticalsAustraliaPtyLimited |
| Australia | (L01EA03) nilotinib (adm: O) | Tasigna 150 mg capsule, 120 | Capsule 150 mg (as hydrochloride monohydrate), 120 pcs | Retail price without vat |
$0-0 |
$0-0 |
Leukemia, Myelogenous, Chronic, BCR-ABL Positive | NovartisPharmaceuticalsAustraliaPtyLimited |
| Australia | (L01EA03) nilotinib (adm: O) | Tasigna 150 mg capsule, 120 | Capsule 150 mg (as hydrochloride monohydrate), 120 pcs | Wholesale price without vat |
$0-0 |
$0-0 |
Leukemia, Myelogenous, Chronic, BCR-ABL Positive | NovartisPharmaceuticalsAustraliaPtyLimited |
| Australia | (L01EA03) nilotinib (adm: O) | Tasigna 150 mg capsule, 120 | Capsule 150 mg (as hydrochloride monohydrate), 120 pcs | Retail price without vat |
$0-0 |
$0-0 |
Leukemia, Myelogenous, Chronic, BCR-ABL Positive | NovartisPharmaceuticalsAustraliaPtyLimited |
| Australia | (L01EA03) nilotinib (adm: O) | Tasigna 150 mg capsule, 120 | Capsule 150 mg (as hydrochloride monohydrate), 120 pcs | Wholesale price without vat |
$0-0 |
$0-0 |
Leukemia, Myelogenous, Chronic, BCR-ABL Positive | NovartisPharmaceuticalsAustraliaPtyLimited |
| Australia | (L01EA03) nilotinib (adm: O) | Tasigna 200 mg capsule, 120 | Capsule 200 mg (as hydrochloride monohydrate), 120 pcs | Retail price without vat |
$0-0 |
$0-0 |
Leukemia, Myelogenous, Chronic, BCR-ABL Positive | NovartisPharmaceuticalsAustraliaPtyLimited |
| Australia | (L01EA03) nilotinib (adm: O) | Tasigna 200 mg capsule, 120 | Capsule 200 mg (as hydrochloride monohydrate), 120 pcs | Retail price without vat |
$0-0 |
$0-0 |
Leukemia, Myelogenous, Chronic, BCR-ABL Positive | NovartisPharmaceuticalsAustraliaPtyLimited |
| Australia | (L01EA03) nilotinib (adm: O) | Tasigna 200 mg capsule, 120 | Capsule 200 mg (as hydrochloride monohydrate), 120 pcs | Retail price without vat |
$0-0 |
$0-0 |
Leukemia, Myelogenous, Chronic, BCR-ABL Positive | NovartisPharmaceuticalsAustraliaPtyLimited |
Pages
